CL2011001097A1 - Composicion de vacuna que comprende e. meleagrimitis 2 y meleagrimitis 1; uso de dicha vacuna para inmunizar un pavo contra la cocciodiosis; metodo para identificar un aislado de eimeria como una eimeria meleagrimitis 2; y kit de amplificacion por pcr. - Google Patents

Composicion de vacuna que comprende e. meleagrimitis 2 y meleagrimitis 1; uso de dicha vacuna para inmunizar un pavo contra la cocciodiosis; metodo para identificar un aislado de eimeria como una eimeria meleagrimitis 2; y kit de amplificacion por pcr.

Info

Publication number
CL2011001097A1
CL2011001097A1 CL2011001097A CL2011001097A CL2011001097A1 CL 2011001097 A1 CL2011001097 A1 CL 2011001097A1 CL 2011001097 A CL2011001097 A CL 2011001097A CL 2011001097 A CL2011001097 A CL 2011001097A CL 2011001097 A1 CL2011001097 A1 CL 2011001097A1
Authority
CL
Chile
Prior art keywords
meleagrimitis
eimeria
vaccine
cocciodiosis
immunize
Prior art date
Application number
CL2011001097A
Other languages
English (en)
Inventor
Steve Hewart Fitz-Coy
Gamini Saman Kumara Withanage
Alexandria Louise Mcgowan
Stephanie M Cook
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of CL2011001097A1 publication Critical patent/CL2011001097A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/70—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Composición de vacuna que comprende E. Meleagrimitis 2 y meleagrimitis 1; uso de dicha vacuna para inmunizar un pavo contra la cocciodiosis; método para identificar un aislado de eimeria como una eimeria meleagrimitis 2; y kit de amplificación por PCR.
CL2011001097A 2008-11-13 2011-05-13 Composicion de vacuna que comprende e. meleagrimitis 2 y meleagrimitis 1; uso de dicha vacuna para inmunizar un pavo contra la cocciodiosis; metodo para identificar un aislado de eimeria como una eimeria meleagrimitis 2; y kit de amplificacion por pcr. CL2011001097A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11420808P 2008-11-13 2008-11-13

Publications (1)

Publication Number Publication Date
CL2011001097A1 true CL2011001097A1 (es) 2012-07-20

Family

ID=41786412

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011001097A CL2011001097A1 (es) 2008-11-13 2011-05-13 Composicion de vacuna que comprende e. meleagrimitis 2 y meleagrimitis 1; uso de dicha vacuna para inmunizar un pavo contra la cocciodiosis; metodo para identificar un aislado de eimeria como una eimeria meleagrimitis 2; y kit de amplificacion por pcr.

Country Status (8)

Country Link
US (1) US8252292B2 (es)
EP (1) EP2355844A2 (es)
AU (1) AU2009314192A1 (es)
BR (1) BRPI0921843B1 (es)
CA (1) CA2743262C (es)
CL (1) CL2011001097A1 (es)
MX (1) MX2011005133A (es)
WO (1) WO2010056709A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201010717A (en) * 2008-05-29 2010-03-16 Intervet Int Bv Coccidiosis vaccines
HUE047484T2 (hu) 2013-02-14 2020-04-28 Univ Arkansas Készítmények és eljárások eimeria elleni immunválasz fokozására vagy eimeria-fertõzés korlátozására
BE1028702B1 (nl) * 2020-10-13 2022-05-16 Poulpharm Bvba Biobank en werkwijze voor het in stand houden van deze biobank

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5649323A (en) * 1979-09-29 1981-05-02 Nisshin Flour Milling Co Ltd Coccidiostat
JPS5780325A (en) * 1980-09-05 1982-05-19 Nat Res Dev Coccidial disease vaccine
GB8326633D0 (en) 1983-08-04 1983-11-09 Unilever Plc Compositions
JP3020226B2 (ja) * 1986-08-18 2000-03-15 ブリティッシュ・テクノロジー・グループ・リミテッド ワクチン
NZ221560A (en) 1986-08-28 1989-10-27 Lilly Co Eli Method of protecting animals against coccidiosis by the oral administration of infective coccidial organisms
US4935007A (en) * 1986-08-28 1990-06-19 Eli Lilly And Company Anticoccidial method
GB8711256D0 (en) 1987-05-13 1987-06-17 Unilever Plc Protection
ZA954785B (en) * 1994-06-16 1996-02-08 Yamanouchi Pharma Co Ltd Crude drug-containing feed
HU223707B1 (hu) * 1995-06-07 2004-12-28 Pfizer Inc. Eimeria sporozoiták vagy merozoiták alkalmazása coccidiózis elleni in ovo vakcinázásra szolgáló vakcina előállítására
EP0831896B1 (en) 1995-06-07 2001-06-27 Pfizer Inc. In ovo vaccination against coccidiosis
CA2213385A1 (en) 1997-08-20 1999-02-20 Eng-Hong Lee Method of protecting against coccidiosis infections in poultry
CA2214233A1 (en) * 1997-08-29 1999-02-28 Eng-Hong Lee Method for assessing viability of live microbial therapeutic agents
AUPP268398A0 (en) 1998-03-30 1998-04-23 Eimeria Pty Limited Vaccination modalitites
DE19828322A1 (de) 1998-06-25 1999-12-30 Hoechst Roussel Vet Gmbh Coccidienvakzine, Verfahren zu ihrer Herstellung und ihre Verwendung
US7247309B2 (en) * 1999-12-21 2007-07-24 Intervet International B.V. Coccidiosis vaccines
AUPQ622900A0 (en) * 2000-03-15 2000-04-06 University Of Melbourne, The Pcr-based identification of eimeria species and strains
US6432646B1 (en) * 2000-03-16 2002-08-13 The University Of Melbourne PCR-based identification of Eimeria species and strains
EP1359799A2 (en) * 2000-11-08 2003-11-12 Novus International, Inc. Methods and compositions for the control of coccidiosis
US6969602B1 (en) * 2001-04-20 2005-11-29 The United States Of America As Represented By The Secretary Of The Agriculture Production of an immunovariant strain of Eimeria maxima contributes to strain cross-protection with other Eimeria maximas
EP1421178B1 (en) * 2001-08-30 2010-10-13 Embrex, Inc. Improved methods for producing oocysts
TWI348376B (en) * 2002-02-26 2011-09-11 Wyeth Corp Selection of poultry eimeria strains through extra-intestinal sporozites
CA2486618C (en) * 2002-05-21 2013-04-09 Schering-Plough Ltd. Methods for the in vitro culture of sporozoea sp. and uses thereof
AU2003270274B2 (en) 2002-09-20 2009-03-19 Intervet International B.V. Live attenuated parasite vaccine
RU2324498C2 (ru) * 2002-12-09 2008-05-20 Юниверсити Оф Джорджия Рисерч Фаундейшн, Инк. Кокцидиальная вакцина и методы ее приготовления и использования
US7354593B2 (en) 2002-12-09 2008-04-08 Merial Limited Coccidial vaccine and methods of making and using same
DK1742656T3 (da) 2004-03-12 2010-07-19 Univ Georgia Hidtil ukendt jordnøddeskindekstrakt som adjuvansvaccine
CA2464522C (en) * 2004-04-15 2011-11-15 Eng-Hong Lee Soft gel delivery system for treating poultry
US20080131463A1 (en) * 2006-11-30 2008-06-05 Perdue Holdings, Inc. Vaccination method for controlling coccidiosis in fowl
TW201010717A (en) * 2008-05-29 2010-03-16 Intervet Int Bv Coccidiosis vaccines

Also Published As

Publication number Publication date
CA2743262A1 (en) 2010-05-20
US8252292B2 (en) 2012-08-28
BRPI0921843B1 (pt) 2020-11-24
US20100166803A1 (en) 2010-07-01
MX2011005133A (es) 2011-08-04
EP2355844A2 (en) 2011-08-17
AU2009314192A1 (en) 2010-05-20
WO2010056709A2 (en) 2010-05-20
AU2009314192A2 (en) 2011-06-23
WO2010056709A3 (en) 2010-07-01
CA2743262C (en) 2021-11-02
BRPI0921843A2 (pt) 2018-10-09

Similar Documents

Publication Publication Date Title
DOP2010000328A (es) Inhibidores de bace
DOP2011000084A (es) Uso de ditiina-tetracarboximidas para combatir hongos fitopatogenos
UY32049A (es) Inhibidores de cmet
TR201910320T4 (tr) Karaciğer organoidi, kullanımları ve elde edilmesine yönelik kültür yöntemi.
GT201200276A (es) Combinaciones de compuestos activos
AR075501A1 (es) Uso de inhibidores de la succinato deshidrogenasa para combatir infecciones primarias por oidio
CO6331297A2 (es) Composiciones adyuvantes novedosas
CO6511229A2 (es) Metodos para reducir la actividad viricida en composiciones pcv-2 y composiciones pcv-2 con una inmunogeicidad mejorada
EA201270019A1 (ru) Двуцепочечная рнк, включенная в липидный состав и мишенью которой является ген pcsk9
CR20120011A (es) Inhibidores de bace
CL2011002082A1 (es) Composicion farmaceutica que comprende un inhibidor de nucleosido polimerasa y un inhibidor de proteasa macrociclica; proceso para preparar dicha composicion farmaceutica; metodo para tratar o mejorar una infeccion con virus de la hepatitis c, fibrosis hepatica y alteracion de la funcion hepatica.
BRPI0909820A2 (pt) Processo para estabilização de composição de vacina contra gripe, para estabilização de composição de vacina contendo adjuvante e para preparação de vacina, composições de vacina, kit de vacina e método de estocagem de uma matéria prima
CR20140318A (es) Composiciones intranasales de dexmedetomidina y métodos de uso de ellas
CL2012000590A1 (es) Proceso para preparar w-transaminasa (r)-selectiva.
SV2010003593A (es) Nuevos herbicidas
CL2011000098A1 (es) Uso de una betadefensina de mamifero para tratar enfermedad inflamatoria.
BRPI0914069A2 (pt) composição de vacina para uso contra o influenza
HN2011001247A (es) Inhibidores de cinana akt y p70 s6
CL2009001804A1 (es) Uso de un copolimero de vinilamina-vinilformamida y un portador para preparar una composicion destinada a fortalecer las fibras queratinosas.
BR112013007514A2 (pt) anticorpo isolado, uso da composição e método
CL2012002246A1 (es) Proceso para producir un extracto de alergenos; extracto de alergenos; uso de un extracto de alergenos para tratar alergia a los cacahuetes; composicion farmacéutica que comprende dicho extracto; vacuna que comprende un extracto de alergenos.
CL2011000262A1 (es) Virus de bronquitis infecciosa (bi) derivado de un virus similar a qx-bi; composicion de vacuna que comprende dicho virus; procedimiento para preparar dicho virus.
CL2011001097A1 (es) Composicion de vacuna que comprende e. meleagrimitis 2 y meleagrimitis 1; uso de dicha vacuna para inmunizar un pavo contra la cocciodiosis; metodo para identificar un aislado de eimeria como una eimeria meleagrimitis 2; y kit de amplificacion por pcr.
CL2011003080A1 (es) Composicion fungicida que comprende tolclofos-metilo, fosfato de polioxietilen poliarilfenol, copolimero de bloque de polioxietileno polioxipropileno, eter de alcohol graso de polioxietileno y agua.
ECSP13012520A (es) Proceso para la preparación de inhibidores de pan-cdk de la fórmula (i), e intermediarios de la preparación